Oriana Romano

University of Padua — Italy

Medicine · Health Sciences

16h-index1.8kcitations44works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(13), CRISPR and Genetic Engineering(11), Prenatal Screening and Diagnostics(5), RNA modifications and cancer(5), Genomics and Chromatin Dynamics(4)

Publications44 total

<i>SpaceTrooper</i> : a quality control framework for imaging-based spatial omics data
2025
Base editing of β <sup>0</sup> -thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies
Science Translational Medicine·2025
RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressiveness
Journal of Experimental & Clinical Cancer Research·2025· 2 citedOpen Access
Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease
Cell Reports Medicine·2025Open Access
Base editing of β <sup>0</sup> thalassemia mutations as a therapeutic strategy for β-hemoglobinopathies: efficacy and genotoxicity studies
2025Open Access
Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies
Nucleic Acids Research·2025· 1 citedOpen Access
Multiplex base editing of <i>BCL11A</i> regulatory elements to treat sickle cell disease
2024· 1 citedOpen Access
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis
Molecular Therapy — Methods & Clinical Development·2024· 5 citedOpen Access
Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses
Molecular Therapy·2024· 19 citedOpen Access
Safety and efficacy study of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific response
2024Open Access
Cities and regions for a blue economy
Notes Internacionals CIDOB·2023Open Access
Ciudades y regiones para una economía azul
Notes Internacionals CIDOB·2023Open Access
High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy
The American Journal of Human Genetics·2023· 4 citedOpen Access
Ricostruzione di traiettorie dinamiche dal potenziale di differenziamento di singole cellule
IRIS UNIMORE (University of Modena and Reggio Emilia)·2023
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
Molecular Therapy — Nucleic Acids·2023· 14 citedOpen Access
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies
2022· 2 citedOpen Access
Targeted Base Editing Strategies for Beta-Hemoglobinopathies
Blood·2022· 1 cited
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
Nature Communications·2022· 68 citedOpen Access
popsicleR: A R Package for Pre-processing and Quality Control Analysis of Single Cell RNA-seq Data
Journal of Molecular Biology·2022· 19 citedOpen Access
Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ
Nature Communications·2021· 111 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Annarita Miccio(22), Silvio Bicciato(18), Tristan Félix(12), Mario Amendola(10), Fulvio Mavilio(10), Panagiotis Antoniou(9), Pierre Martinucci(9), Clelia Peano(9), Mattia Forcato(8), Giulia Hardouin(8), Anne Chalumeau(8), Marina Cavazzana(7), Cécile Masson(5), Mégane Brusson(5), Marco Severgnini(5), Gianluca De Bellis(5), Valentina Poletti(5), Giuliana Ferrari(5), Chiara Antoniani(4), Laure Joseph(4)